KDMN Kadmon Holdings LLC gains 33% Feb 2, 2018

Kadmon Holdings, LLC, a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics to address unmet medical needs. The company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; co-promotes a product for chronic weight management; distributes products for chorea, cytomegalovirus retinitis, and for the prevention of CMV disease. It is also developing product candidates in autoimmune and fibrotic diseases, oncology, and genetic diseases. The company is headquartered in New York, New York. http://www.priceseries.com/trade/KDMN-Kadmon-Holdings-LLC-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2018011120180202.html